Genevieve Kanter
@profgenkanter.bsky.social
Economist and Associate Professor (University of Southern California, Public Policy) geeking out on biomed technologies, FDA, conflicts of interest, ethics in health care and government
Pinned
New JAMA study: Conflicts of interest on CDC vaccine panel were at historic lows prior to RFK Jr dismissal
▪️although ACIP COI levels were high in 2000 (~40%), they have ⬇️ since then
▪️since 2016, ACIP COIs have been 6%
t.co/HKH6z1LC6F
@schaeffer.usc.edu
@priceschool.usc.edu
▪️although ACIP COI levels were high in 2000 (~40%), they have ⬇️ since then
▪️since 2016, ACIP COIs have been 6%
t.co/HKH6z1LC6F
@schaeffer.usc.edu
@priceschool.usc.edu
Reposted by Genevieve Kanter
NEW: FDA review staff was excluded from voting on whether to approve first priority voucher drug. Top leaders like Vinay Prasad, George Tidmarsh, and Tracy Høeg led the vote instead. Read for the full list, and expert reaction from @hollylynchez.bsky.social: www.statnews.com/2025/11/21/t...
FDA review staff was excluded from voting on whether to approve first priority voucher drug
Top officials like Vinay Prasad and George Tidmarsh voted on the drug, a major break from the FDA's typical practice.
www.statnews.com
November 21, 2025 at 4:33 PM
NEW: FDA review staff was excluded from voting on whether to approve first priority voucher drug. Top leaders like Vinay Prasad, George Tidmarsh, and Tracy Høeg led the vote instead. Read for the full list, and expert reaction from @hollylynchez.bsky.social: www.statnews.com/2025/11/21/t...
Reposted by Genevieve Kanter
The entire HR department at the CDC is gone. Everyone at the IRB, which makes sure studies are conducted ethically and rigorously, and the ethics office, which oversee conflicts of interest for CDC leaders and advisory committee members, were also let go.
www.theguardian.com/us-news/2025...
www.theguardian.com/us-news/2025...
‘Instability and confusion’ as CDC slashes 1,300 jobs before reinstating half
Trump administration says 700 notices were sent in error, while top CDC officer says ‘they didn’t think through what they were doing’
www.theguardian.com
October 14, 2025 at 3:13 PM
The entire HR department at the CDC is gone. Everyone at the IRB, which makes sure studies are conducted ethically and rigorously, and the ethics office, which oversee conflicts of interest for CDC leaders and advisory committee members, were also let go.
www.theguardian.com/us-news/2025...
www.theguardian.com/us-news/2025...
Reposted by Genevieve Kanter
USC rejects Trump education compact aimed at shifting the university to the right www.latimes.com/california/s...
USC rejects Trump education compact aimed at shifting the university to the right
USC interim President Beong-Soo Kim said in a statement that he had sent a letter to the U.S. Department of Education turning down the Trump offer.
www.latimes.com
October 16, 2025 at 9:08 PM
USC rejects Trump education compact aimed at shifting the university to the right www.latimes.com/california/s...
Reposted by Genevieve Kanter
After getting zero firm commitments to this point from the first nine invitees, the Trump administration is extending its proposed compact to all colleges. Expect some red-state publics to say yes.
Trump Offers All Colleges Preferential Funding Plan Rejected by MIT
The Trump administration is inviting all US colleges to participate in a compact — initially rejected by the Massachusetts Institute of Technology — that would grant preferential federal funding in re...
www.bloomberg.com
October 13, 2025 at 10:17 PM
After getting zero firm commitments to this point from the first nine invitees, the Trump administration is extending its proposed compact to all colleges. Expect some red-state publics to say yes.
Reposted by Genevieve Kanter
Joel Mokyr, Philippe Aghion and Peter Howitt won the Nobel memorial prize in economics Monday for their research on how technological innovation fuels economic growth and creative destruction. n.pr/4oh42lZ
3 share Nobel Prize in Economics for work on technology, growth and creative destruction
Joel Mokyr, Philippe Aghion and Peter Howitt won the Nobel memorial prize in economics Monday for their research on how technological innovation fuels economic growth and creative destruction.
n.pr
October 13, 2025 at 11:35 AM
Joel Mokyr, Philippe Aghion and Peter Howitt won the Nobel memorial prize in economics Monday for their research on how technological innovation fuels economic growth and creative destruction. n.pr/4oh42lZ
Reposted by Genevieve Kanter
NEW: @CDCgov hit hard by massive firings that several staff describe to me as a “bloodbath.”
Among those RIFd:
—leadership of the center for immunization and respiratory diseases;
—leadership of global health center
—leadership of the measles outbreak response; 1/4
Among those RIFd:
—leadership of the center for immunization and respiratory diseases;
—leadership of global health center
—leadership of the measles outbreak response; 1/4
October 11, 2025 at 12:49 PM
NEW: @CDCgov hit hard by massive firings that several staff describe to me as a “bloodbath.”
Among those RIFd:
—leadership of the center for immunization and respiratory diseases;
—leadership of global health center
—leadership of the measles outbreak response; 1/4
Among those RIFd:
—leadership of the center for immunization and respiratory diseases;
—leadership of global health center
—leadership of the measles outbreak response; 1/4
Reposted by Genevieve Kanter
We have breaking news in Inside Medicine.
We had heard rumors of RIFs to CDC.
But this is the first visual confirmation that it has occurred tonight, and at high levels in the agency.
Here is what we know...and then some well-sourced rumors (but rumors, nonetheless, not confirmed) 🧵...
We had heard rumors of RIFs to CDC.
But this is the first visual confirmation that it has occurred tonight, and at high levels in the agency.
Here is what we know...and then some well-sourced rumors (but rumors, nonetheless, not confirmed) 🧵...
October 11, 2025 at 3:17 AM
We have breaking news in Inside Medicine.
We had heard rumors of RIFs to CDC.
But this is the first visual confirmation that it has occurred tonight, and at high levels in the agency.
Here is what we know...and then some well-sourced rumors (but rumors, nonetheless, not confirmed) 🧵...
We had heard rumors of RIFs to CDC.
But this is the first visual confirmation that it has occurred tonight, and at high levels in the agency.
Here is what we know...and then some well-sourced rumors (but rumors, nonetheless, not confirmed) 🧵...
Reposted by Genevieve Kanter
I have been off bluesky for a while - but this is a good reason to be back. Check out the latest from me, @reshmagar.bsky.social & @hollylynchez.bsky.social!
With thanks to the many folks whose work informed this piece, incl @rachelsachs.bsky.social , @sbagen.bsky.social @drjoshs.bsky.social...
With thanks to the many folks whose work informed this piece, incl @rachelsachs.bsky.social , @sbagen.bsky.social @drjoshs.bsky.social...
New from @pzettler.bsky.social @reshmagar.bsky.social + me in @jhppl.bsky.social.
We describe themes driving historic FDA reforms, explain how what's happening under Trump2 is different + call for principles to guide FDA reform and activity across administrations.
read.dukeupress.edu/jhppl/articl...
We describe themes driving historic FDA reforms, explain how what's happening under Trump2 is different + call for principles to guide FDA reform and activity across administrations.
read.dukeupress.edu/jhppl/articl...
October 9, 2025 at 3:53 PM
I have been off bluesky for a while - but this is a good reason to be back. Check out the latest from me, @reshmagar.bsky.social & @hollylynchez.bsky.social!
With thanks to the many folks whose work informed this piece, incl @rachelsachs.bsky.social , @sbagen.bsky.social @drjoshs.bsky.social...
With thanks to the many folks whose work informed this piece, incl @rachelsachs.bsky.social , @sbagen.bsky.social @drjoshs.bsky.social...
Aaand (checks notes) right on schedule...
We found that about 1/3 of FDA appointees go to industry within 2 years after their exit from the agency (rates were even higher at CDC and CMS).
www.healthaffairs.org/doi/10.1377/...
We found that about 1/3 of FDA appointees go to industry within 2 years after their exit from the agency (rates were even higher at CDC and CMS).
www.healthaffairs.org/doi/10.1377/...
October 7, 2025 at 8:26 PM
Aaand (checks notes) right on schedule...
We found that about 1/3 of FDA appointees go to industry within 2 years after their exit from the agency (rates were even higher at CDC and CMS).
www.healthaffairs.org/doi/10.1377/...
We found that about 1/3 of FDA appointees go to industry within 2 years after their exit from the agency (rates were even higher at CDC and CMS).
www.healthaffairs.org/doi/10.1377/...
Consolidation in the EHR market -- where there are 2 dominant vendors -- is creating a big risk of a catastrophic cybersecurity event.
@ajh.bsky.social, @natea.bsky.social, and I ponder the possibility of a "single-point-of-failure" risk in the EHR market in this Health Affairs Scholar commentary
@ajh.bsky.social, @natea.bsky.social, and I ponder the possibility of a "single-point-of-failure" risk in the EHR market in this Health Affairs Scholar commentary
Electronic health record market consolidation and implications for cybersecurity
Abstract. Over the past decade, the electronic health record (EHR) market has become increasingly consolidated, with the majority of care delivery organiza
academic.oup.com
October 7, 2025 at 12:59 PM
Consolidation in the EHR market -- where there are 2 dominant vendors -- is creating a big risk of a catastrophic cybersecurity event.
@ajh.bsky.social, @natea.bsky.social, and I ponder the possibility of a "single-point-of-failure" risk in the EHR market in this Health Affairs Scholar commentary
@ajh.bsky.social, @natea.bsky.social, and I ponder the possibility of a "single-point-of-failure" risk in the EHR market in this Health Affairs Scholar commentary
Reposted by Genevieve Kanter
“If you are just focused on [IRB] turnaround time, that doesn’t tell you really anything about quality,” said Holly Fernandez Lynch . . . She added: “It inhibits people from saying, ‘Wait, we need to pause on this. Is this the right thing to do?’”
www.nytimes.com/2025/10/04/h...
www.nytimes.com/2025/10/04/h...
How Private Equity Oversees the Ethics of Drug Research
www.nytimes.com
October 4, 2025 at 12:54 PM
“If you are just focused on [IRB] turnaround time, that doesn’t tell you really anything about quality,” said Holly Fernandez Lynch . . . She added: “It inhibits people from saying, ‘Wait, we need to pause on this. Is this the right thing to do?’”
www.nytimes.com/2025/10/04/h...
www.nytimes.com/2025/10/04/h...
Reposted by Genevieve Kanter
NIH may create an Open Payments-style database to track health industry funding of research. USC Schaeffer's @profgenkanter.bsky.social tells @science.org that transparency is generally good but warns: "The devil is in the details."
NIH promises to create conflict-of-interest database for scientists, but offers few details
Proposed system would mirror Open Payments program for tracking industry payments to doctors
www.science.org
September 24, 2025 at 4:52 PM
NIH may create an Open Payments-style database to track health industry funding of research. USC Schaeffer's @profgenkanter.bsky.social tells @science.org that transparency is generally good but warns: "The devil is in the details."
Reposted by Genevieve Kanter
In @jama.com, we identify a blind spot for FDA-listed AI/ML devices 🤖🔍
Over 90% have no reported manufacturer payments to clinicians or hospitals in Open Payments (US disclosure database)
As AI enters care, transparency can’t lag
jamanetwork.com/journals/jam...
Over 90% have no reported manufacturer payments to clinicians or hospitals in Open Payments (US disclosure database)
As AI enters care, transparency can’t lag
jamanetwork.com/journals/jam...
Payments by AI- and Machine Learning–Enabled Medical Device Manufacturers
This study examines the extent and nature of payments made to health care professionals and teaching hospitals by manufacturers of FDA-authorized AI- and machine learning–enabled devices.
jamanetwork.com
September 22, 2025 at 5:27 PM
In @jama.com, we identify a blind spot for FDA-listed AI/ML devices 🤖🔍
Over 90% have no reported manufacturer payments to clinicians or hospitals in Open Payments (US disclosure database)
As AI enters care, transparency can’t lag
jamanetwork.com/journals/jam...
Over 90% have no reported manufacturer payments to clinicians or hospitals in Open Payments (US disclosure database)
As AI enters care, transparency can’t lag
jamanetwork.com/journals/jam...
Reposted by Genevieve Kanter
The deadline to sign up to be a volunteer chair or discussant for #2025APPAM is quickly approaching! Chairs guide session prep, & discussants spark great conversations. Sign up by Wed, Sept 24th: ow.ly/o5AH50WJRAm
September 15, 2025 at 5:44 PM
The deadline to sign up to be a volunteer chair or discussant for #2025APPAM is quickly approaching! Chairs guide session prep, & discussants spark great conversations. Sign up by Wed, Sept 24th: ow.ly/o5AH50WJRAm
Reposted by Genevieve Kanter
Reposted by Genevieve Kanter
Reposted by Genevieve Kanter
The #FDA is shifting away from longstanding practice of having outside experts review drug applications. This could mean less public scrutiny and external input on agency decisions, USC Schaeffer Sr. Scholar @profgenkanter.bsky.social tells @kffhealthnews.org.
Under Trump, FDA Seeks To Abandon Expert Reviews of New Drugs - KFF Health News
Advisory committee meetings help FDA scientists make decisions and increase public understanding of drug regulation, and abandoning them doesn’t make sense, former officials said.
kffhealthnews.org
September 12, 2025 at 4:09 PM
The #FDA is shifting away from longstanding practice of having outside experts review drug applications. This could mean less public scrutiny and external input on agency decisions, USC Schaeffer Sr. Scholar @profgenkanter.bsky.social tells @kffhealthnews.org.
Did not have this on my bingo card this year - abandoning FDA advisory committee review of new drugs.
Had an interesting, wide-ranging convo with Art Allen at @kffhealthnews.org on the whys, wherefores, and wtfs of this policy change
kffhealthnews.org/news/article...
Had an interesting, wide-ranging convo with Art Allen at @kffhealthnews.org on the whys, wherefores, and wtfs of this policy change
kffhealthnews.org/news/article...
Under Trump, FDA Seeks To Abandon Expert Reviews of New Drugs - KFF Health News
Advisory committee meetings help FDA scientists make decisions and increase public understanding of drug regulation, and abandoning them doesn’t make sense, former officials said.
kffhealthnews.org
September 12, 2025 at 2:34 PM
Did not have this on my bingo card this year - abandoning FDA advisory committee review of new drugs.
Had an interesting, wide-ranging convo with Art Allen at @kffhealthnews.org on the whys, wherefores, and wtfs of this policy change
kffhealthnews.org/news/article...
Had an interesting, wide-ranging convo with Art Allen at @kffhealthnews.org on the whys, wherefores, and wtfs of this policy change
kffhealthnews.org/news/article...
Reposted by Genevieve Kanter
@edthestorm.bsky.social (@ihs.ac.at) is presenting a paper measuring the effects of AI (such as machine learning, not generative AI) on employment stability and earnings
Expertise is key for extracting earnings gains and employment stability
Average workers see no impacts of AI on their outcomes
Expertise is key for extracting earnings gains and employment stability
Average workers see no impacts of AI on their outcomes
September 11, 2025 at 10:02 AM
@edthestorm.bsky.social (@ihs.ac.at) is presenting a paper measuring the effects of AI (such as machine learning, not generative AI) on employment stability and earnings
Expertise is key for extracting earnings gains and employment stability
Average workers see no impacts of AI on their outcomes
Expertise is key for extracting earnings gains and employment stability
Average workers see no impacts of AI on their outcomes
Reposted by Genevieve Kanter
Do you have a timely policy-related research topic you want to present at #2025APPAM? You are in luck! We are accepting late-breaking roundtables through Sept. 24th! Learn more: ow.ly/9NRe50WTjvU
September 8, 2025 at 3:51 PM
Do you have a timely policy-related research topic you want to present at #2025APPAM? You are in luck! We are accepting late-breaking roundtables through Sept. 24th! Learn more: ow.ly/9NRe50WTjvU
Reposted by Genevieve Kanter
At RFK, Jr.'s disastrous hearing yesterday, Senator Bill Cassidy cited a study co-authored by CSPI president @drpeterlurie.bsky.social and USC's @profgenkanter.bsky.social regarding conflicts of interest. Is RFK, Jr. right when he says that 97% of members of vaccine panels had conflicts of interest?
September 5, 2025 at 11:03 PM
At RFK, Jr.'s disastrous hearing yesterday, Senator Bill Cassidy cited a study co-authored by CSPI president @drpeterlurie.bsky.social and USC's @profgenkanter.bsky.social regarding conflicts of interest. Is RFK, Jr. right when he says that 97% of members of vaccine panels had conflicts of interest?
Reposted by Genevieve Kanter
Reposted by Genevieve Kanter
Business & academic economists, please check it out. If you agree, please sign and share here, by email, with your colleagues, your friends, your associations, by any means possible.
Private sector voices carry weight with relevant audiences.
#FinTwit #NumbersDay #EconSky
Private sector voices carry weight with relevant audiences.
#FinTwit #NumbersDay #EconSky
Update: we are at 379 signatures in support of Lisa Cook and Fed independence!
The letter be open for signatures through Sun. (Link to sign at the top).
If you are on X or listservs, please spread the word there!
docs.google.com/document/d/1...
The letter be open for signatures through Sun. (Link to sign at the top).
If you are on X or listservs, please spread the word there!
docs.google.com/document/d/1...
Open letter
Click here to add your signature. An Open Letter from Economists in Support of Governor Lisa Cook and Federal Reserve Independence To the President, Members of Congress, and the American public: We wr...
docs.google.com
August 29, 2025 at 1:25 PM
Business & academic economists, please check it out. If you agree, please sign and share here, by email, with your colleagues, your friends, your associations, by any means possible.
Private sector voices carry weight with relevant audiences.
#FinTwit #NumbersDay #EconSky
Private sector voices carry weight with relevant audiences.
#FinTwit #NumbersDay #EconSky
Reposted by Genevieve Kanter
Over 125 economists signed the open letter calling on the President, Congress, and the American public to uphold the principles of Federal Reserve independence and not remove Lisa Cook without due process.
There's still time to sign! And please share.
#EconSky
docs.google.com/document/d/1...
There's still time to sign! And please share.
#EconSky
docs.google.com/document/d/1...
Open letter
Click here to add your signature. An Open Letter from Economists in Support of Governor Lisa Cook and Federal Reserve Independence To the President, Members of Congress, and the American public: We wr...
docs.google.com
August 27, 2025 at 10:04 PM
Over 125 economists signed the open letter calling on the President, Congress, and the American public to uphold the principles of Federal Reserve independence and not remove Lisa Cook without due process.
There's still time to sign! And please share.
#EconSky
docs.google.com/document/d/1...
There's still time to sign! And please share.
#EconSky
docs.google.com/document/d/1...
Reposted by Genevieve Kanter
Update to this sad and crazy CDC day, via @drmaligator.medsky.social :
Abbe Lowell and I represent CDC Director #SusanMonarez. Contrary to govt statements, Dr. Monarez has neither resigned nor yet been fired. She will not resign. We have issued the following statement:
August 28, 2025 at 12:04 AM
Update to this sad and crazy CDC day, via @drmaligator.medsky.social :